SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Sharck Soup -- Ignore unavailable to you. Want to Upgrade?

To: Sharck who wrote (21119)5/8/2001 8:00:23 AM
From: Electric  Read Replies (2) | Respond to of 37746
 
It looks like CSCO wont be pushed down today, in fact with 2 large firms supporting the stock INTO earnings, it may be a sign of a bottom on the stock. Look for the markets to react nicely to this and rally strongly. I am suprised to see the upgrades, not in a bad way though..lol



To: Sharck who wrote (21119)5/8/2001 8:06:41 AM
From: 2MAR$  Read Replies (2) | Respond to of 37746
 
BGEN Stock Hurt by Competing MS Drug Data

Boston, May 08, 2001 (Midnight Trader via COMTEX) -- Biogen is trading lower
today on 5,100 Instinet shares after Reuters reported that Zurich-based Serono
SA released data that said its multiple sclerosis drug was more effective than
Biogen's product. The U.S. FDA has yet to approve Serono's product for use in
the states. Serono is advancing 0.59 to 23.50 on Instinet.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News